Skip to content

Evaluation of folliculogenesis in poor responds women after intrauterine injection of autologous platelet-rich plasma

Evaluation of folliculogenesis in poor responds women after intrauterine injection of autologous platelet-rich plasma

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220510054808N1
Enrollment
32
Registered
2022-05-15
Start date
2022-05-26
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with poor ovarian response.

Interventions

Intervention 1: Control group: A group of poor ovarian reserve women who undergo follicular puncture without any treatment. Intervention 2: Intervention group: A group of poor ovarian reserve women u

Sponsors

Ghoum University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 40 Years

Inclusion criteria

Inclusion criteria: previous IVF (In vitro fertilisation) that resulted in the recovery of less than three eggs or an abnormal ovarian reserve test involving less than five AFCs (Antral follicle count ) All women have a regular menstrual cycle. the level of follicles or AMH (Antimullerian Hormone) should be less than 1.1 ng / ml. those under 40 years of age.

Exclusion criteria

Exclusion criteria: Autoimmune disorders, sexually transmitted diseases, infectious diseases, infertility / tubal factor tube obstruction, chronic inflammatory diseases, endometriosis, chronic endometritis, and endocrine disorders such as thyroid dysfunction. anemia, thrombophilic disorders, current cancer diagnosis, or medical history of cancer

Design outcomes

Primary

MeasureTime frame
Platelet-enriched plasma cell count. Timepoint: After plasma preparation. Method of measurement: With cell counting machine.

Secondary

MeasureTime frame
Expression of folliculogenesis genes. Timepoint: After collecting granulosa cells on the day of oocyte someone both the control group and the treated group. Method of measurement: Real time PCR.;Hormone secretion levels. Timepoint: At monthly intervals after the puncture and before the puncture. Method of measurement: Immunoassay.;Antral follicle count. Timepoint: At monthly intervals after the puncture and before the puncture. Method of measurement: sonography.;The quality of oocytes. Timepoint: after puncture. Method of measurement: with stereomicroscope.;Oocyte and embryo quality. Timepoint: after puncture. Method of measurement: With a stereomicroscope.;Spontaneous fertility. Timepoint: 14 days after embryo transfer. Method of measurement: Pregnancy test and sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Asgari

Ghoum University of Medical Sciences

faasgsri@muq.ac.ir+98 25 3711 8428

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026